486 related articles for article (PubMed ID: 8673092)
1. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
[TBL] [Abstract][Full Text] [Related]
2. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
[TBL] [Abstract][Full Text] [Related]
3. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB; Boyd AA; Volcik K; Richards CS
Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
[TBL] [Abstract][Full Text] [Related]
4. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
[TBL] [Abstract][Full Text] [Related]
5. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
7. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
[TBL] [Abstract][Full Text] [Related]
8. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.
Beller U; Halle D; Catane R; Kaufman B; Hornreich G; Levy-Lahad E
Gynecol Oncol; 1997 Nov; 67(2):123-6. PubMed ID: 9367693
[TBL] [Abstract][Full Text] [Related]
9. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
Krainer M; Silva-Arrieta S; FitzGerald MG; Shimada A; Ishioka C; Kanamaru R; MacDonald DJ; Unsal H; Finkelstein DM; Bowcock A; Isselbacher KJ; Haber DA
N Engl J Med; 1997 May; 336(20):1416-21. PubMed ID: 9145678
[TBL] [Abstract][Full Text] [Related]
10. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls.
Muto MG; Cramer DW; Tangir J; Berkowitz R; Mok S
Cancer Res; 1996 Mar; 56(6):1250-2. PubMed ID: 8640808
[TBL] [Abstract][Full Text] [Related]
11. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ
Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
[TBL] [Abstract][Full Text] [Related]
12. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
Schorge JO; Mahoney NM; Miller DS; Coleman RL; Muller CY; Euhus DM; Tomlinson GE
Gynecol Oncol; 2001 Nov; 83(2):383-7. PubMed ID: 11606101
[TBL] [Abstract][Full Text] [Related]
13. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
14. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
[TBL] [Abstract][Full Text] [Related]
15. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.
Struewing JP; Abeliovich D; Peretz T; Avishai N; Kaback MM; Collins FS; Brody LC
Nat Genet; 1995 Oct; 11(2):198-200. PubMed ID: 7550349
[TBL] [Abstract][Full Text] [Related]
16. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.
FitzGerald MG; MacDonald DJ; Krainer M; Hoover I; O'Neil E; Unsal H; Silva-Arrieto S; Finkelstein DM; Beer-Romero P; Englert C; Sgroi DC; Smith BL; Younger JW; Garber JE; Duda RB; Mayzel KA; Isselbacher KJ; Friend SH; Haber DA
N Engl J Med; 1996 Jan; 334(3):143-9. PubMed ID: 8531968
[TBL] [Abstract][Full Text] [Related]
17. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.
Petrukhin L; Dangel J; Vanderveer L; Costalas J; Bellacosa A; Grana G; Daly M; Godwin AK
Cancer Res; 1997 Dec; 57(24):5480-4. PubMed ID: 9407954
[TBL] [Abstract][Full Text] [Related]
18. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.
Gershoni-Baruch R; Dagan E; Fried G; Kepten I; Robinson E
Eur J Hum Genet; 1999; 7(7):833-6. PubMed ID: 10573018
[TBL] [Abstract][Full Text] [Related]
20. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
